STOCK TITAN

RLI Corp (NYSE: RLI) awards 12,500 stock options to its chief operating officer

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

RLI Corp reported that chief operating officer Jennifer L. Klobnak received a grant of 12,500 stock options on August 3, 2026. The options have an exercise price of $61.29 per share, vest in 20% annual increments starting one year after grant, and expire on August 3, 2034.

Positive

  • None.

Negative

  • None.
Insider Klobnak Jennifer L
Role CHIEF OPERATING OFFICER
Type Security Shares Price Value
Grant/Award Stock Option F1 12,500 $0.00 $0.00
Holdings After Transaction: Stock Option — 12,500 shares (Direct)
Footnotes (1)
  1. F1. Pursuant to option schedule wherein 20% of the aggregate number of shares granted may be exercised commencing one year from grant date and each year thereafter in 20% increments.
Stock options granted 12,500 options Grant to COO Jennifer L. Klobnak on 2026-08-03
Exercise price $61.29 per share Conversion or exercise price of granted stock options
Vesting rate 20% per year Portion of options becoming exercisable each year from one year after grant
First exercisability date 2027-08-03 Earliest date options may be exercised under the schedule
Expiration date 2034-08-03 Date after which the options can no longer be exercised
Options held after transaction 12,500 options Total derivative securities following the reported grant
Stock Option financial
"security_title: "Stock Option" related to the COO grant"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
conversion_or_exercise_price financial
"conversion_or_exercise_price: "61.2900" for the granted options"
underlying_security_shares financial
"underlying_security_shares: "12500.0000" indicating common shares tied to options"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did RLI (RLI) disclose for Jennifer L. Klobnak?

RLI disclosed that COO Jennifer L. Klobnak received a grant of 12,500 stock options on August 3, 2026. The options relate to RLI common stock and represent a compensation award rather than an open-market purchase or sale of existing shares.

What is the exercise price of the new stock options granted at RLI (RLI)?

The granted stock options carry an exercise price of $61.29 per share. This is the price at which Klobnak may buy RLI common shares under the option, subject to vesting and exercisability terms described in the award schedule.

How do the RLI (RLI) stock options granted to the COO vest over time?

The stock options vest in 20% increments each year. According to the schedule, 20% of the aggregate 12,500 options become exercisable one year after the grant date, with an additional 20% becoming exercisable each year thereafter until fully vested.

When can the newly granted RLI (RLI) options first be exercised and when do they expire?

The options may first be exercised beginning August 3, 2027, one year after grant. They have a stated expiration date of August 3, 2034, after which any unexercised options will no longer be exercisable by the reporting person.

How many RLI (RLI) derivative securities does the COO hold after this option grant?

Following the transaction, Jennifer L. Klobnak is reported as holding 12,500 stock options directly. These options are derivative securities tied to RLI common stock and reflect the entire amount granted in this award transaction.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Klobnak Jennifer L

(Last)(First)(Middle)
9025 N. LINDBERGH DRIVE

(Street)
PEORIA ILLINOIS 61615

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
RLI CORP [ RLI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CHIEF OPERATING OFFICER
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option$61.2908/03/2026A12,50008/03/2027(1)08/03/2034Common Stock12,500$012,500D
Explanation of Responses:
1. Pursuant to option schedule wherein 20% of the aggregate number of shares granted may be exercised commencing one year from grant date and each year thereafter in 20% increments.
/s/ Jennifer L. Klobnak08/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)